Cognition peptides
Registered in Russia, with dosing instructions behind them. That's a fact about the products, not about whether they work.
Semax and Selank have the same Russian maker, Peptogen. Both are registered as medicines in Russia, and neither is FDA-approved. Registration means the product was approved there, and it comes with instructions for how to use it. It doesn't mean there's the amount of evidence you'd expect behind an approved drug.
Semax has been studied in healthy people, but thinly. A 1997 summary by its developers reports better memory and attention in healthy men under extreme conditions. Its abstract doesn't say how that study was designed, how many people took part, or whether there was a comparison group. Two brain-scan studies followed, in 24 and 52 healthy volunteers, each with a placebo group. They measured how brain areas connect at rest, not whether the volunteers thought more clearly. One of Semax's developers is an author on both, so neither is an outside group checking the first claim. The Alzheimer's Drug Discovery Foundation, whose neuroscientists reviewed Semax, found there's little evidence it helps thinking in healthy people.
Selank is different. Its registered uses are anxiety states, including asthenia (weakness and lack of energy) and poor sleep, and stress disorders, not problems with memory or attention. We found five studies of it in people, and all five share an author, Myasoedov, from one of the two institutes that developed it. Four tested it in people with anxiety and related disorders, two of them also with neurasthenia (nervous exhaustion). Three of those measured symptoms, mostly with rating scales, in 60 to 70 people each, and one measured immune markers in the blood. One of the three reported mild effects on thinking, and another found that adding it to phenazepam, a tranquilizer, reduced that drug's side effects on attention and memory. The fifth, a brain-scan study in 52 healthy volunteers, included it alongside Semax. Apart from those reports and studies in animals, the case we found for it as a cognition peptide rests on the maker's own description of how it works, which mentions effects on memory, attention and learning. A maker's description of how a drug works isn't evidence of results in people. Keeping those three things apart is most of what this page is for.
So the honest reading is neither "approved, so it works" nor "no evidence at all". These are registered products with dosing instructions, though only Semax's give doses by weight. The evidence on memory and focus is small, measures things mostly indirectly, and none of the studies above comes from a group with no stake in the result.
In this group
- SemaxA short peptide built on a piece of a stress hormone, with doses in its registered instructions but thin evidence as a nootropic, for memory and focus.Registered as a medicine in Russia, where it's dispensed only on prescription; not approved by the FDA.
- SelankAn anxiety medicine registered in Russia, discussed for memory and focus.Registered as a medicine in Russia, where it's dispensed without a prescription; not approved by the FDA.
What we don't cover
These pages don't cover side effects, who shouldn't take them (contraindications), or drug interactions. The exceptions are the FDA's safety notes on compounded Semax (mixed from its ingredients by a pharmacist or doctor) and on compounded Selank, each on its own page, and one study's report on Selank taken with phenazepam. They make no claims that either peptide works. N-Acetyl Semax and its amidate are modified forms of Semax. Those are different molecules from the one described here.
Get an early invite to Tidepath
The app isn't in the App Store yet. Leave your email for an early invite, and tips for your first month.
Get an early invite, tips and occasional news from Tidepath. Unsubscribe anytime. Privacy · Health data privacy · Sender and contact details